Global Microcarrier Market Report By Product Type (Consumables ((Microcarrier Beads, Media & Reagents)), Equipment), Application (Cell Therapy, Vaccine Manufacturing, Others) End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes), Countries and Company Analysis 2024-2032

Driving forces for microcarrier market

Rising biopharmaceutical demand—Due to their success in treating a wide range of illnesses, biopharmaceuticals have become more well-known, and they are essential to the creation of these biotherapeutics. The need for micro-carriers as a substrate for cell culture in bioprocessing is anticipated to rise as the pharmaceutical industry continues to move toward biologics and customized medicine. This component is a result of the requirement for efficient and scalable procedures for the growth and expansion of cells, which carriers enable. The market is continuing to increase as a result of the biopharmaceutical industry's continuous R&D activities as well as the expansion of biomanufacturing facilities. Furthermore, the COVID-19 pandemic has increased the need for therapeutic proteins and vaccines, highlighting the critical role that bioproduction plays in these fields.

Developments in treatments based on cells- The market is expanding as a result of the quick developments in cell-based therapeutics, especially in immunotherapy and regenerative medicine. These treatments entail the culture and growth of immunological or patient-derived cells, which calls for the application of as a support matrix for cell proliferation. Demand has increased as a result of the growing emphasis on customized care and the creation of cutting-edge therapies for illnesses like cancer, autoimmune diseases, and tissue regeneration. Furthermore, cell culture systems' adaptability, scalability, and reproducibility make them essential for producing cell treatments, which presents a promising market outlook. The US FDA has authorized Flucelvax Quadrivalent, a cell culture-based influenza vaccine, for use in anyone six months of age and older, according to the CDC. The current pandemic and rising rates of infectious and chronic illnesses are anticipated to propel the microcarrier market and produce rapid expansion over the projected timeframe.

Stem cell research's expansion- The field of stem cell research is vibrant and promising, with potential applications in basic science and medicine. In order to research developmental processes or for therapeutic purposes, they are commonly used for the multiplication of stem cells. In addition, the market is expanding globally due to rising interest in regenerative medicine and growing funding for stem cell research. Microcarriers are utilized by researchers and biotechnology corporations to offer a regulated atmosphere for stem cell growth and differentiation. This is crucial for the advancement of cell-based medicines and tissue engineering.

North America Microcarrier Market

The region's growth has been aided by the hike in the prevalence of infectious and chronic diseases, a greater understanding of personalized medicine, improved healthcare infrastructure and reimbursement schemes, the existence of major market participants, and extensive research and development. Moreover, novel cell-based therapeutics are entering the market as a result of regulatory support for biopharmaceuticals and regenerative medicines. For instance, based on the present trial success rates and product pipeline, the U.S. FDA estimates that by 2025, it will be approving roughly 10 to 20 cell and gene therapy items annually. Furthermore, as per  a data sheet released by the US FDA in November 2021, there are roughly 621 licensed biologics products. Constant product approvals and the biomanufacturing industry's expansion will fuel the microcarriers market's existence in North America.

Microcarrier Company Analysis

The top microcarrier companies are Thermo Fisher Scientific, Merck KGaA, Eppendorf AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Inc., Corning Inc., Lonza Group, Getinge and Becton, Dickinson and Company.

Microcarrier Company News

January 2024, PangenomiX array was introduced by Thermo Fisher Scientific Inc. to aid in pharmacogenomics research and population-scale disease studies.

October 2023, A top-notch thermal cycler called the Mastercycler® X40 has been introduced by Eppendorf AG. With its user-friendly interface, adaptable compatibility for tubes and plates, sample protection, temperature optimization, and effective program migration, the Mastercycler X40 improves PCR.

June 2023, Teijin Ltd. introduced nonwoven microcarriers, a brand-new product. Improving large-scale cell culture was the primary goal of this launch. The launch of this product will contribute to the expansion of the range of cell types.

June 2023, NovoMATRIX received funding from NOVA. The firm will benefit from this investment by introducing stem cell therapy to the market. Through this agreement, the companies will eventually expand their product portfolio base and offer a variety of cell therapy choices to its clients.

May 2022, BeadMATRIX was introduced by Saint-Gobain Life Sciences to enhance mesenchymal stem cells (MSCs). BeadMATRIX are ready-to-use, pre-coated carriers that are devoid of animal components and are widely utilized in in vitro MSC cultivation. The company will grow its market share and improve its base of products with this launch.

 FAQs

Question:    What is the current size of the global microcarrier market?

Answer:     The global microcarrier market was valued at USD 1.89 Billion in 2023.

Question:    What is the projected growth rate of the microcarrier market?

Answer:     The market is expected to grow at a compound annual growth rate (CAGR) of 8.87% from 2024 to 2032.

Question:    Which region dominates the microcarrier market?

Answer:     North America holds the largest share of the microcarrier market.

Question:    What are the key factors driving the growth of the microcarrier market?

Answer:     The growth factors of microcarrier market include rising biopharmaceutical demand, developments in treatments based on cells and stem cell research's expansion.

Question:    Who are the key players in the microcarrier market?

Answer:     Major players of microcarrier include Thermo Fisher Scientific, Eppendorf AG, Merck KGaA, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Inc., Corning Inc., Lonza Group, Getinge and Becton, Dickinson and Company.

Product– Market breakup in 2 viewpoints:

1. Consumables

1.1 Microcarrier Beads

1.2 Media & Reagents

2. Equipment

Application– Market breakup in 3 viewpoints:

1. Cell Therapy
2. Vaccine Manufacturing
3. Others

End User– Market breakup in 3 viewpoints:

1. Pharmaceutical & Biotechnology Companies
2. Contract Research Organizations & Contract Manufacturing Organizations
3. Academic & Research Institutes

Country – Market breakup of 25 Countries:

1. North America

1.1    United States

1.2    Canada

2. Europe

2.1    France

2.2    Germany

2.3    Italy

2.4    Spain

2.5    United Kingdom

2.6    Belgium

2.7    Netherland

2.8    Turkey

3. Asia Pacific

3.1    China

3.2    Japan

3.3    India

3.4    South Korea

3.5    Thailand

3.6    Malaysia

3.7    Indonesia

3.8    Australia

3.9    New Zealand

4. Latin America

4.1    Brazil

4.2    Mexico

4.3    Argentina

5. Middle East & Africa

5.1    Saudi Arabia

5.2    UAE

5.3   South Africa

6. Rest of the world

All the key players have been covered from 4 Viewpoints:

• Business Overview
• Product Portfolio
• Recent Development & Strategies
• Revenue Analysis

Key Players Analysis:

1. Thermo Fisher Scientific
2. Merck KGaA
3. Eppendorf AG
4. Danaher Corporation
5. Sartorius AG
6. Bio-Rad Laboratories, Inc.
7. Corning Inc.
8. Lonza Group
9. Getinge
10. Becton, Dickinson and Company

Report Details: